Found 11 matching trials
Intravesical Adjuvant Electromotive Mitomycin-C PHASE2 In laboratory and clinical studies, intravesical electromotive drug adminis...
Show More Location
Tor Vergata University, Department of experimental Medicine and Surgery/Urology
Learn More & Join Trial
Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer PHASE4 The investigartors will conduct a randomized, multinational study with the ...
Show More Location
Aalborg University Hospital
Learn More & Join Trial
Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC NA This study will evaluate whether adjuvant intravesical chemotherapy can be ...
Show More Location
Daqing Oil General Hopital
Learn More & Join Trial
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I PHASE3 A multi-institutional, prospective, randomised, open-label, superiority, co...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) PHASE3 This is a randomized, multicenter, two-arm, double-blind, placebo-controlle...
Show More Location
University of Wisconsin
Learn More & Join Trial
Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer EARLY_PHASE1 Hypothesis: In selected patients external hyperthermia will be used in comb...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy N/A Retrospective monocentric study evaluating different immunohistochemical ph...
Show More Location
Humanitas reseach hospital (ICH)
Learn More & Join Trial
Phase II Trial of EOquin in High-risk Superficial Bladder Cancer PHASE2 A non-randomized, open-label phase II study to explore the feasibility, tim...
Show More Location
St Radboud University Hospital
Learn More & Join Trial
Antitumor T Cell Responses in Patients With Bladder Cancer N/A The main objective of this study is to evaluate the induction of Th1 anti-T...
Show More Location
Multiple Locations
Learn More & Join Trial
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial NA The objective of this prospective, single-center randomized controlled tria...
Show More Location
Mansoura Urology and Nephrology Center
Learn More & Join Trial